Medical accreditors commit to HHS nutrition education reforms

HHS and the U.S. Department of Education announced several developments in their efforts to improve nutrition education in medical schools.
According to an HHS press release, eight medical accrediting, assessment and board organizations have “committed to implementing reforms aimed at instilling measurable nutritional education across key medical training programs.” The groups are:
HHS also announced that 19 additional medical schools have voluntarily committed to requiring at least 40 hours of nutrition education or a competency equivalent beginning this fall. They join the 54 other medical

US receives first new sunscreen ingredient in 2 decades

The FDA has added bemotrizinol to the over-the-counter sunscreen monograph, making it the first new active sunscreen ingredient permitted in the United States since 1999, according to an agency press release.
The final order allows bemotrizinol to be added as an active ingredient to sunscreen formulations at concentrations up to 6%, the FDA reported. The decision comes within 7 months of the agency’s previously issued proposed order in December 2025.
“As promised in the Trump Administration’s MAHA Strategy Report, HHS is advancing innovation by bringing a new sunscreen ingredient to the U.S.

As Ebola spreads, Rubio says US will ‘reengage’ with global vaccine alliance

Secretary of State Marco Rubio said last week that the United States would “reengage” with Gavi, the Vaccine Alliance, nearly a year after HHS Secretary Robert F. Kennedy Jr. pulled funding for the global vaccine distributor.
Rubio made the comments during a hearing in front of the Senate Committee on Foreign Relations, noting that President Donald J. Trump had requested that Kennedy manage the relationship with Gavi — something that was traditionally done by the U.S. Department of State.
When Kennedy announced last June that the U.S. was pulling funding for Gavi, he claimed the organization

Mortality higher in patients with epilepsy in rural areas

Individuals with epilepsy who lived in rural locations were twice as likely to die in the hospital as those from urban locations, according to findings from Neurology.
“Previous research has demonstrated that rural communities experience worse outcomes and reduced access to neurologic care in diseases such as stroke and multiple sclerosis, but this association has not been systematically evaluated in epilepsy,” Edward R. Bader, MBChB, MS, of Albert Einstein College of Medicine, told Healio.
“Working in an academic center in a large city, we were particularly curious how geography and access to

VIDEO: ‘Exciting time’ in treatment landscape of IgA nephropathy

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the current treatment landscape in IgA nephropathy.
Cravedi, professor in the division of nephrology at the Icahn School of Medicine at Mount Sinai, highlights the recent “explosion” of new treatments for IgA nephropathy and the debate over how best to use these medications.
“It’s a very exciting time ... because now we can test different strategies to treat and, probably in some cases, even cure the disease,” Cravedi said.

VIDEO: Pathophysiological model of IgA nephropathy ‘extremely helpful’ in drug development

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the pathophysiology of IgA nephropathy, focusing on the “four-hit” hypothesis.
“The four-hit hypothesis ... is the working model for how we interpret the pathophysiology of this disease,” said Cravedi, assistant professor in the division of nephrology at the Icahn School of Medicine at Mount Sinai.
Recent data have revealed some weaknesses in the hypothesis, Cravedi said.
“Despite [the limitations] of this model, we think that it has been

Dihydropyridine CCB may worsen kidney outcomes in type 2 diabetes

Dihydropyridine calcium channel blockers may be linked to worse kidney outcomes for patients with type 2 diabetes, according to study data presented at the European Renal Association Congress in Glasgow, Scotland.
Dihydropyridine calcium channel blockers (DCCBs) are a commonly prescribed antihypertensive medication for patients with diabetic kidney disease, according to Timna Agur, MD, senior nephrologist at Rabin Medical Center in Israel. Agur and colleagues sought to understand what effect DCCBs, in conjunction with renin-angiotensin system inhibitors and SGLT2 inhibitors, have on kidney

AI scribes may have ‘profound impact’ on patient care

Since 2019, burnout has been defined in the ICD-11 as a “syndrome resulting from chronic workplace stress that has not been successfully managed.”
In particular, Kayden Chahal and Kabir Matwala wrote in their 2024 systematic review that orthopedic surgeons face many challenges within practice, including litigation issues and bureaucratic demands, which can lead to burnout. In fact, the systematic review found a mean burnout prevalence of 48.9% among 8,471 orthopedic surgeons, with a range in the rate of burnout of 15% to 90.4% between studies.
Another study by Shuting Lu, BS, and colleagues

Skin cancer burden increasing in certain regions worldwide

Although melanoma incidence has continued to decline in high-income countries, rates for other types of skin cancers have grown globally, particularly in lower-income countries, researchers reported.
In North America, melanoma incidence declined by 10.5% from 1990 to 2023, whereas cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC) incidence rates continued to increase by 154.1% and 34.5%, respectively, according to a research letter in JAMA Dermatology. In regions with low- and middle-sociodemographic index (SDI) scores, the researchers observed a rising incidence of all

‘Intriguing’ findings link first-time seizure to cancer risk

First-time seizures are associated with significantly higher short-term risk for cancer — including malignancies that develop outside the central nervous system, according to results of a population-based cohort study.
An analysis of nearly 50,000 adults who experienced a first-time seizure revealed they had a 76-fold greater likelihood than the general population to develop neurological malignancies within the next year.
These individuals exhibited more than double the risk for non-neurological cancers during that same period. Long-term risk remained slightly elevated.
“These results underscore